Policy & Law
Williams··2 min read
Trump's 200% Generic Drug Tariff Threat: A Geopolitical Shock to Global Pharma
President Trump announced a phased tariff plan for generic drugs, reaching 200% by 2028, to force manufacturing back to the US. Indian pharma stocks dipped, while industry leaders like Sandoz are seeking dialogue. Analysts cite WTO conflicts and potential supply shortages.
